TDS Pharm Co (XKRX:464280) Dividends per Share : ₩0.00 (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Dividends per Share?

TDS Pharm Co's dividends per share for the three months ended in Mar. 2025 was ₩0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, TDS Pharm Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

TDS Pharm Co Dividends per Share Historical Data

The historical data trend for TDS Pharm Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Dividends per Share Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Dividends per Share	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of TDS Pharm Co's Dividends per Share

For the Drug Manufacturers - General subindustry, TDS Pharm Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TDS Pharm Co's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where TDS Pharm Co's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

TDS Pharm Co Dividends per Share Calculation

Dividends paid to per common share.

TDS Pharm Co (XKRX:464280) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

TDS Pharm Co's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	69
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

TDS Pharm Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines